Xeris Pharmaceuticals | XERS - 销售收入

金融业

USD

USD 392.01M

现金及等价物

USD 111.75M

USD 13.66M

USD 251.68M

USD 118.59M

USD 257.65M

USD 16.77M

USD 25.09M

377

EPS每股收益

USD 0.01

股本和储备

USD 13.01M

USD 72.15M

债务利息支出

USD 7.15M

USD 1.16M

USD 221.22M

USD 976.2M

USD 11.08M

USD 69.03M

USD 16.77M

普通股股本

USD 166.22M

2.45K

USD 11.08M

USD 83.13M

销售和管理费用

USD 42.64M

USD 74.23M

贸易债权人

USD 11.47M

应收帐款人

USD 51.05M

	销售	更改		日
Celltrion	KRW 1.15T		180B	2026-03
Cspc Pharmaceutical	CNY 6.47B		355.1M	2026-03
Deva Holding AS	TRY 2.32B		418.58M	2023-09
Dianthus Therapeutics	USD 284K		112K	2025-12
Divis Laboratories Ltd	INR 28.31B		2.27B	2026-03
Eli Lilly	USD 19.8B		500M	2026-03
Kangmei Pharma	CNY 1.08B		288.27M	2026-03
Knight Therapeutics	CAD 133.11M		11.56M	2025-12
Laboratorios Farma	EUR 448.66M		67.82M	2023-12
Medical Developments International	AUD 21.57M		12.04M	2025-12
Nektar Therapeutics	USD 21.81M		2.32M	2025-12
Neuren Pharmaceuticals	AUD 42.24M		28.1M	2025-12
Organigram Holdings	CAD 63.54M		16.52M	2025-12
Pacira	USD 177M		19.87M	2026-03
Perrigo	USD 969M		141M	2026-03
Pharma Mar	EUR 42.9M		47.3M	2026-03
Qiagen NV	USD 419.22M		38.16M	2026-03
Sartorius	EUR 899.1M		28.5M	2026-03
Sino Biopharmaceutical	CNY 14.26B		3.31B	2025-12
Supernus Pharmaceuticals	USD 207.71M		3.89M	2026-03
Tilray	USD 217.51M		74.75M	2025-12
Zealand Pharma A/S	68.91M		19.35M	2025-12
Zhangzhou Pientzehuang Pharmaceutical	CNY 2.72B		837.63M	2026-03